Elanco Animal Health Inc at Goldman Sachs Global Healthcare Conference Transcript
Good afternoon, everyone. Thanks a lot for joining us. Again, my name is Nathan Rich, and I cover the animal health space here at Goldman. We're pleased to welcome Elanco for our next session. We have Todd Young, CFO; and Katy Grissom from Investor Relations. Todd, very good to see you. Sorry I couldn't be there in person. COVID had its own plan. So I'm glad to have the opportunity to host virtually at least, and my colleague, Lindsay Golub, is on stage, and she'll jump in with some questions as well. We'll take questions from the audience towards the end if anyone does want to ask a question. Thanks a lot for your time this afternoon.
Questions & Answers
I thought we could maybe start with the company's outlook for the balance of the year, Todd, if that's okay.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |